HK1045104A1 - 用於預防或降低與冠狀動脈介入治療相關的心血管事件的方法 - Google Patents

用於預防或降低與冠狀動脈介入治療相關的心血管事件的方法

Info

Publication number
HK1045104A1
HK1045104A1 HK02105201.2A HK02105201A HK1045104A1 HK 1045104 A1 HK1045104 A1 HK 1045104A1 HK 02105201 A HK02105201 A HK 02105201A HK 1045104 A1 HK1045104 A1 HK 1045104A1
Authority
HK
Hong Kong
Prior art keywords
cariovascular
prevention
reduction
events associated
coronary intervention
Prior art date
Application number
HK02105201.2A
Other languages
English (en)
Inventor
R Granett Jeffrey
H Shusterman Neil
C U'prichard David
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of HK1045104A1 publication Critical patent/HK1045104A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK02105201.2A 1999-02-03 2002-07-12 用於預防或降低與冠狀動脈介入治療相關的心血管事件的方法 HK1045104A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11846299P 1999-02-03 1999-02-03
PCT/US2000/002622 WO2000045811A1 (en) 1999-02-03 2000-02-02 Method for the prevention or reduction of cariovascular events associated with coronary intervention

Publications (1)

Publication Number Publication Date
HK1045104A1 true HK1045104A1 (zh) 2002-11-15

Family

ID=22378750

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02105201.2A HK1045104A1 (zh) 1999-02-03 2002-07-12 用於預防或降低與冠狀動脈介入治療相關的心血管事件的方法

Country Status (17)

Country Link
EP (1) EP1171116A4 (zh)
JP (1) JP2002536327A (zh)
KR (1) KR20010101934A (zh)
CN (1) CN1345237A (zh)
AU (1) AU2636600A (zh)
BR (1) BR0007921A (zh)
CA (1) CA2361581A1 (zh)
CO (1) CO5150206A1 (zh)
HK (1) HK1045104A1 (zh)
HU (1) HUP0200129A3 (zh)
IL (1) IL144721A0 (zh)
MX (1) MXPA01007835A (zh)
NO (1) NO20013788L (zh)
PL (1) PL351397A1 (zh)
TR (1) TR200102245T2 (zh)
WO (1) WO2000045811A1 (zh)
ZA (1) ZA200106353B (zh)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2617407B2 (ja) * 1992-09-14 1997-06-04 キッセイ薬品工業株式会社 血管内膜細胞過剰増殖疾患の予防および治療剤
US5693337A (en) * 1994-07-13 1997-12-02 Wakamoto Pharmaceutical Co., Ltd. Stable lipid emulsion
KR19990044478A (ko) * 1995-09-07 1999-06-25 간자와 무츠와 2-아실아미노벤즈아미드 유도체 및 혈관내막세포 과잉증식에 기인하는 질환의 예방 및 치료제
US6019104A (en) * 1996-12-30 2000-02-01 Kissei Pharmaceutical Co., Ltd. Method for the treatment or prevention of restenosis associated with coronary intervention

Also Published As

Publication number Publication date
HUP0200129A3 (en) 2003-06-30
ZA200106353B (en) 2002-08-02
CO5150206A1 (es) 2002-04-29
BR0007921A (pt) 2002-09-10
CA2361581A1 (en) 2000-08-10
EP1171116A4 (en) 2004-11-17
JP2002536327A (ja) 2002-10-29
AU2636600A (en) 2000-08-25
MXPA01007835A (es) 2002-04-24
CN1345237A (zh) 2002-04-17
EP1171116A1 (en) 2002-01-16
PL351397A1 (en) 2003-04-07
NO20013788D0 (no) 2001-08-02
IL144721A0 (en) 2002-06-30
HUP0200129A2 (hu) 2002-05-29
TR200102245T2 (tr) 2002-05-21
WO2000045811A1 (en) 2000-08-10
NO20013788L (no) 2001-09-28
KR20010101934A (ko) 2001-11-15

Similar Documents

Publication Publication Date Title
NZ514350A (en) Compositions and methods for effecting the levels of cholesterol
GB2352377B (en) Noise suppression method
IL148803A0 (en) Novel composition and method for stabilizing the same
AU5294100A (en) Method and compositions for treating the inflammatory response
IL144114A0 (en) Method for the preparation of 5-cyanophthalide
EP0669362A3 (en) Process for the preparation of polytitanosiloxanes soluble in organic solvents.
HK1052702A1 (en) Method for the preparation of 5-carboxyphthalide.
EP1239855A4 (en) METHOD FOR PREVENTING AND TREATING ARTERIOSCLEROSIS
IL148518A (en) Optoelectronic assembly and method for fabricatingthe same
ZA977565B (en) Method for inhibiting the expression of fas
ZA200107523B (en) Method for improving the stability of stored and/or light-sensitive therapeutic systems or component thereof.
AU2001243248A1 (en) Method for the prevention or reduction of vascular access dysfunction
PL351397A1 (en) Method for the prevention or reduction of cariovascular events associated with coronary intervention
ZA200110474B (en) Method and device for the continuous of NaAlCl4 or NaFeCl4.
PL349926A1 (en) Method for the prevention or reduction of cardiovascular events associated with coronary intervention
AU2001275414A1 (en) Method for the prevention or reduction of cardiovascular events associated with coronary intervention
EP1217232A4 (en) LOCKING NUT
GB0006745D0 (en) Stud for partititioning or the like
TW371925U (en) Structure of the caster
TW437347U (en) Shelving for suspension from rafters or the like
ZA200007580B (en) Materials and methods for prevention or reduction of the severity of heartwater.
TW376949U (en) Improved structure for the venetial blinds of combination type
PL333864A1 (en) Method of controlling the operation of static compensator system
HU9802108D0 (en) Funeral method
TW387240U (en) The chain-wheel controller for curtain